“There’s a major, major issue related to...

“There’s a major, major issue related to how reimbursement works for drugs that are given in the hospital. It causes all kinds of distortions, not just in the supply chain…misaligned incentives are pervasive throughout the system.”   —James Gelfand, president of the ERISA Industry Committee (ERIC), spoke with AIS’s Radar on Drug Benefits about the Biden administration’s executive order directing the CMMI to work to drive down drug costs, and what forms these innovations could take.

 

Subscribers may read the Radar on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.